SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for Venus Concept Inc. (VERO) (CIK 0001409269) (VERO) — Apr 28, 2020

Venus Concept Inc. (VERO) (CIK 0001409269)
Date: April 28, 2020 · CIK: 0001409269 · Accession: 0000000000-20-003648

AI Filing Summary & Sentiment

File numbers found in text: 333-237737

Date
April 28, 2020
Author
Not clearly detected
Form
UPLOAD
Company
Venus Concept Inc. (VERO) (CIK 0001409269)

Letter

United States securities and exchange commission logo April 28, 2020 Domenic DiSisto General Counsel and Corporate Secretary Venus Concept Inc. 235 Yorkland Blvd., Suite 900 Toronto, Ontario M2J 4Y8 Re:Venus Concept Inc. Registration Statement on Form S-3 Filed April 17, 2020 File No. 333-237737 Dear Mr. DiSisto: We have limited our review of your registration statement to those issues we have addressed in our comment. Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe our comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing any amendment to your registration statement and the information you provide in response to the comment, we may have additional comments. Registration Statement on Form S-3 General 1.We note that under Article VIII of your Amended and Restated Certificate of Incorporation that the federal district courts of the United States of America shall be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act. Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder. Please include disclosure in your prospectus to state that there is uncertainty as to whether a court would enforce your exclusive forum provision and that investors cannot waive compliance with the federal securities laws and the rules and regulations thereunder. We also note that your forum selection provision in Article VIII identifies the Court of Chancery of the State of Delaware as the exclusive forum for certain litigation, including any “derivative action.”

FirstName LastNameDomenic DiSisto Comapany NameVenus Concept Inc. April 28, 2020 Page 2 FirstName LastName Domenic DiSisto Venus Concept Inc. April 28, 2020 Page 2 Please disclose whether this provision applies to actions arising under the Exchange Act. In that regard, we note that Section 27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder. If this provision does not apply to actions arising under the Exchange Act, please tell us how you will inform investors in future filings that the provision does not apply to any actions arising under the Exchange Act. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Refer to Rules 460 and 461 regarding requests for acceleration. Please allow adequate time for us to review any amendment prior to the requested effective date of the registration statement. Please contact Chris Edwards at (202) 551-6761 or Mary Beth Breslin at (202) 551- 3625 with any other questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Danielle Carbone, Esq.

Show Raw Text
United States securities and exchange commission logo
April 28, 2020
Domenic DiSisto
General Counsel and Corporate Secretary
Venus Concept Inc.
235 Yorkland Blvd., Suite 900
Toronto, Ontario M2J 4Y8
Re:Venus Concept Inc.
Registration Statement on Form S-3
Filed April 17, 2020
File No. 333-237737
Dear Mr. DiSisto:
            We have limited our review of your registration statement to those issues we have
addressed in our comment.
            Please respond to this letter by amending your registration statement and providing the
requested information.  If you do not believe our comment applies to your facts and
circumstances or do not believe an amendment is appropriate, please tell us why in your
response.
            After reviewing any amendment to your registration statement and the information you
provide in response to the comment, we may have additional comments.
Registration Statement on Form S-3
General
1.We note that under Article VIII of your Amended and Restated Certificate of
Incorporation that the federal district courts of the United States of America shall be the
exclusive forum for the resolution of any complaint asserting a cause of action arising
under the Securities Act. Section 22 of the Securities Act creates concurrent jurisdiction
for federal and state courts over all suits brought to enforce any duty or liability created by
the Securities Act or the rules and regulations thereunder. Please include disclosure
in your prospectus to state that there is uncertainty as to whether a court would enforce
your exclusive forum provision and that investors cannot waive compliance with the
federal securities laws and the rules and regulations thereunder.  We also note that your
forum selection provision in Article VIII identifies the Court of Chancery of the State of
Delaware as the exclusive forum for certain litigation, including any “derivative action.”

 FirstName LastNameDomenic DiSisto
 Comapany NameVenus Concept Inc.
 April 28, 2020 Page 2
 FirstName LastName
Domenic DiSisto
Venus Concept Inc.
April 28, 2020
Page 2
Please disclose whether this provision applies to actions arising under the Exchange Act.
In that regard, we note that Section 27 of the Exchange Act creates exclusive federal
jurisdiction over all suits brought to enforce any duty or liability created by the Exchange
Act or the rules and regulations thereunder.  If this provision does not apply to actions
arising under the Exchange Act, please tell us how you will inform investors in future
filings that the provision does not apply to any actions arising under the Exchange Act.
            We remind you that the company and its management are responsible for the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action or absence of
action by the staff.
            Refer to Rules 460 and 461 regarding requests for acceleration.  Please allow adequate
time for us to review any amendment prior to the requested effective date of the registration
statement.
            Please contact Chris Edwards at (202) 551-6761 or Mary Beth Breslin at (202) 551-
3625 with any other questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:       Danielle Carbone, Esq.